SCHEMBL13440883

SCHEMBL13440883

Cc1cc(C)nc(Sc2c(O)c3c(=O)[nH]c4ccccc4c3oc2=O)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 7/20 0.41
POLB P06746 1/20 0.41
DAO P14920 1/20 0.41
DDO Q99489 1/20 0.41
HPGD P15428 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 4/20 0.38
IDE P14735 1/20 0.38
MPI P34949 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
TP53 P04637 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CHEK1 O14757 1/20 0.38
GLA P06280 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13440872 0.82 KDM4E (0.43) KDM4EALDH1A1DAODDOHPGD
SCHEMBL13440879 0.77 TUBB4A (0.47) KDM4EALDH1A1POLBDAODDO
SCHEMBL13440882 0.77 TYMS (0.41) KDM4EALDH1A1DAOMEN1KMT2A
SCHEMBL13440871 0.77 TUBB4A (0.50) KDM4EALDH1A1POLBHPGDMEN1
SCHEMBL13440880 0.75 L3MBTL1 (0.45) KDM4EALDH1A1MAPTIDEMPI
SCHEMBL13440866 0.72 KDM4E (0.49) KDM4EALDH1A1POLBDAODDO
SCHEMBL13442175 0.72 MMP2 (0.36) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL13440842 0.69 ALDH1A1 (0.48) KDM4EALDH1A1POLBHPGDMEN1
SCHEMBL11229401 0.67 ALDH1A1 (0.49) KDM4EALDH1A1POLBDAODDO
SCHEMBL9781515 0.66 CDK5 (0.64) KDM4EALDH1A1POLBHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 US disclosed
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF NSUN3, TARBP1, TRMT1 KDM4E 2676/4885ALDH1A1 3494/4885POLB 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.